Serna Bio

serna.bio

Serna Bio is an AI-enabled drug discovery company focused on developing small molecules that modulate translation and splicing for challenging-to-drug targets, addressing diseases with high unmet medical needs. By leveraging synthetic biology, machine learning, and multiplex screening, they tackle the complexities of drugging the transcriptome. Their unique approach includes a comprehensive understanding of RNA architecture and the establishment of the world's largest database of functional RNA structures, which supports both internal programs and collaborations.